Long
Easy 90% Target Mapped for Status (SNT)

SNTBTC printed a candle 11-Feb. that hit above all EMAs, including MA200.
A correction followed and we saw the EMA200 brown line being tested as support.
Today, SNTBTC is moving back above all EMAs, only missing EMA300 and MA200, grey and black lines on the chart.
Above these levels, EMA300 and MA200, SNTBTC can print massive growth.
Here we are looking at a 90% target but over time this altcoin pair can grow so much more.
Additional details on the chart.
Namaste.
A correction followed and we saw the EMA200 brown line being tested as support.
Today, SNTBTC is moving back above all EMAs, only missing EMA300 and MA200, grey and black lines on the chart.
Above these levels, EMA300 and MA200, SNTBTC can print massive growth.
Here we are looking at a 90% target but over time this altcoin pair can grow so much more.
Additional details on the chart.
Namaste.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +1450% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +563% · SOL +658%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6499
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.